Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial Article

sustainable development goals

publication date

  • October 1, 2021

webpage

published in

start page

  • 1141

end page

  • 1153

volume

  • 9

issue

  • 10